Biomarin Pharmaceutical (BMRN) Debt Ratio (2010 - 2024)

Biomarin Pharmaceutical has disclosed Debt Ratio across 15 years of filings, most recently posting 0.07 for Q2 2024.

• Quarterly Debt Ratio changed N/A year-over-year to 0.07 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 0.07 (changed N/A YoY) and the FY2023 annual result came in at 0.07, changed N/A from the prior year.
• Debt Ratio slipped to 0.07 in Q2 2024, from 0.07 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.08 in Q1 2020 and troughed at 0.0 in Q3 2022.
• A 5-year average of 0.04 and a median of 0.01 in 2022 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2020 — Debt Ratio soared 2989.55% — and 2021, when it sank 93.15%.
• Tracing BMRN's Debt Ratio over 5 years: stood at 0.06 in 2020, then plunged by 86.78% to 0.01 in 2021, then tumbled by 43.75% to 0.0 in 2022, then surged by 1497.65% to 0.07 in 2023, then retreated by 3.0% to 0.07 in 2024.
• Business Quant data shows BMRN's Debt Ratio at 0.07 in Q2 2024, 0.07 in Q1 2024, and 0.07 in Q4 2023.